IRulya Therapeutics Inc 10-Q for FY2023 Q1
IRulya Therapeutics Inc. (IRLA)
10-Q
2023-05-15
For: 2023-03-31
View Original
Added on
April 05, 2026
About this 10-Q
IRulya Therapeutics Inc filed this 10-Q on May 15, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).
Headline figures
Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $12.25M
- compared with a net loss of $21.64M a year earlier
- Diluted EPS
- -$0.34
- compared with -$0.72 a year earlier